PPARA and Alzheimer disease: Fenofibrate: A peroxisome proliferator-activated receptor-alpha (PPAR-α) agonist, fenofibrate modulates lipid metabolism and has demonstrated anti-inflammatory effects on microglia, attenuating neuroinflammation and improving cognitive outcomes in preclinical AD models [107].